Skip to main content

Table 3 Data on the clinical daptomycin use in patients with staphylococcal periprosthetic joint infection

From: Daptomycin treatment in patients with resistant staphylococcal periprosthetic joint infection 

Study

No of patients

Daptomycin dose (median, mg/kg/day)

Daptomycin duration (median, days)

Adverse event (%)

Success rate (%)

Antony et al. [29] (2006)

8

6.0

42

6.5

75.0

Rao et al. [21] (2006)

11

4.0

42

NA

54.5

Antony et al. [28] (2009)

30

6.0

37

3.3

66.7

Corona et al. [16] (2012)

14

6.6

44

21.4

78.6

Byren et al. [17] (2012)

24

6.0

42

8.0

58.3

13

8.0

42

16.7

60.9

Our study

16

8.3

14

6.3

87.5